This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated TSLP Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TSLP WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~18.1 kDa | |
| Gel | 12–15% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | N-glycosylation adds mass | |
| Regulation | LPS-induced | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for TSLP — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Gel % | 12–15% |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 18 kDa |
TSLP's 18.1 kDa precursor mass shifts upward in the secreted mature protein mainly due to N-glycosylation at two asparagine sites.
| Band running higher than the 18.1 kDa predicted mass, sometimes appearing diffuse | N-glycosylation at Asn64 and Asn119 adds carbohydrate mass and heterogeneity to the mature chain |
| Band smaller than the full 159-residue precursor size | Cleavage of the 28-residue N-terminal signal peptide removes mass to generate the secreted mature chain |
| No band, or only a faint band, in whole-cell lysate | TSLP is a secreted cytokine, so it is exported from the cell rather than retained intracellularly |
| An extra band at a different apparent molecular weight from the main band | The two annotated splice isoforms (1 and 2) can generate an additional species from alternative processing |
| Band migrates slightly faster (more compact) under non-reducing versus reducing conditions | The three intrachain disulfide bonds hold the folded protein in a compact conformation until reduced |
| Predicted mass (18.1 kDa, 159 aa precursor) | Sets the baseline unmodified backbone size before processing or glycosylation are accounted for |
| Signal peptide cleavage (residues 1-28) | Removes the N-terminal signal sequence so the secreted mature chain runs smaller than the full-length precursor |
| N-glycosylation at Asn64 and Asn119 | Adds carbohydrate mass and glycoform heterogeneity, shifting the mature band upward and sometimes broadening it |
| Splice isoforms 1 and 2 | Can generate an additional band at a qualitatively different apparent molecular weight from alternative exon usage |
| Three intrachain disulfide bonds | Stabilize a compact folded conformation that can make the non-reduced band migrate faster than the fully reduced band |
| Secreted extracellular localization | Means the protein accumulates in conditioned medium or serum rather than in whole-cell lysate |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | TSLP is a secreted cytokine that is exported out of the cell rather than retained intracellularly | Probe concentrated culture supernatant, conditioned medium, or serum/plasma instead of, or in addition to, whole-cell lysate |
| Band higher than expected | N-glycosylation at Asn64 and Asn119 adds carbohydrate mass above the 18.1 kDa predicted backbone | Treat the sample with PNGase F to deglycosylate and check for a shift back toward the predicted mass |
| Broad smear instead of sharp band | Heterogeneous glycan occupancy at the two N-glycosylation sites produces a range of glycoform masses | Run a lower-percentage gel for better resolution or deglycosylate the sample before loading to sharpen the band |
| Multiple bands | The two annotated splice isoforms, or incomplete versus complete signal-peptide processing, can produce species of different size | Compare against a mature-protein standard and confirm isoform identity by mass spec or an isoform-specific reagent if needed |
| Band lower than expected | Incomplete N-glycosylation or use of a non-glycosylated bacterially expressed recombinant standard can reduce apparent mass | Compare lysate bands against a mammalian-expressed recombinant TSLP standard rather than a bacterial one |
| Weak or no signal | TSLP is a low-abundance secreted cytokine typically present at low baseline levels unless the tissue or cells are stimulated | Use a stimulus known to induce TSLP expression, concentrate conditioned medium, and increase total protein loaded |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for TSLP, answered from its protein features.
BosterBio's TSLP antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-TSLP antibody is a best-performing, extensively cited reagent, rigorously validated by Western blot and cross-checked against negative tissue and complementary detection methods for confident, reproducible TSLP detection.
Which to pick: Only one anti-TSLP antibody is listed, A01096, which includes an actual Western blot validation image using recombinant human TSLP protein, making it the clear, and only, choice for this application.